Neogen Chemicals Adjusts Evaluation Score Amidst Growth and Debt Concerns

Neogen Chemicals, a small-cap player in the specialty chemicals industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a sideways position to a mildly bullish outlook.
The company's current stock price stands at 1654.60, showing a notable increase from the previous close of 1616.05. Over the past year, Neogen Chemicals has generated a return of 4.20%, while its profits have increased by 23.6%. However, the company has faced challenges, including a high Debt to EBITDA ratio of 2.96 times, indicating a lower capacity to service its debt obligations.

Despite these hurdles, Neogen Chemicals maintains a significant institutional holding of 30.54%, suggesting a level of confidence from larger investors who typically have more resources to analyze company fundamentals. The operating profit growth over the last five years has been modest at an annual rate of 15.50%, reflecting concerns about long-term growth potential.

Overall, the recent evaluation adjustment highlights the complexities surrounding Neogen Chemicals' market position and financial metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.